BioLineRx Ltd. (BLRX)
NASDAQ·Healthcare·Biotechnology
$3.43
-1.30%
Mkt Cap $11.49M
No analyst coverage available
We don't have analyst ratings or price target data for BioLineRx Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.